Beyond the IgG4 Antibody Subclass in Musk Myasthenia Gravis: Novel Evidence for the Pathogenicity of IgG1,2 and 3

被引:0
|
作者
Cao, Michelangelo [1 ]
Cossins, Judith [1 ]
Liu, Weiwei [1 ]
Maxwell, Susan [1 ]
Webster, Richard [1 ]
Beeson, David [1 ]
Vincent, Angela [1 ]
机构
[1] Univ Oxford, Oxford, England
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
401
引用
收藏
页码:S48 / S49
页数:2
相关论文
共 50 条
  • [41] IMBALANCED SERUM IGG SUBCLASS PATTERN IN TOXIC SHOCK SYNDROME PATIENTS - DEFICIENCY OF SPECIFIC IGG1 AND IGG4 SUBCLASS ANTIBODIES TO TOXIC SHOCK SYNDROME TOXIN-1
    CHRISTENSSON, B
    JOHANSSON, PJH
    OXELIUS, VA
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1986, 66 (02): : 443 - 449
  • [42] Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection
    Beenhouwer, David O.
    Yoo, Esther M.
    Lai, Chun-Wei
    Rocha, Miguel A.
    Morrison, Sherie L.
    INFECTION AND IMMUNITY, 2007, 75 (03) : 1424 - 1435
  • [43] IMMUNOGLOBULINS IN ATAXIA-TELANGIECTASIA - EVIDENCE FOR IGG4 AND IGA2 SUBCLASS DEFICIENCIES
    RIVATPERAN, L
    BURIOT, D
    SALIER, JP
    RIVAT, C
    DUMITRESCO, SM
    GRISCELLI, C
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1981, 20 (01): : 99 - 110
  • [44] PH GRADIENT ELUTION OF HUMAN IGG1, IGG2 AND IGG4 FROM PROTEIN A-SEPHAROSE
    DUHAMEL, RC
    SCHUR, PH
    BRENDEL, K
    MEEZAN, E
    JOURNAL OF IMMUNOLOGICAL METHODS, 1979, 31 (3-4) : 211 - 217
  • [45] Remediation of IGG4 cross reaction from the binding site OPTILITE® IGG1 and IGG2 assays
    Coley, M.
    Sharp, K.
    Kay, A.
    Stubbs, P.
    Harding, S.
    CLINICA CHIMICA ACTA, 2019, 493 : S96 - S96
  • [46] 3 MONOCLONAL IGG COMPONENTS, AN IGG4(LAMBDA), AN IGG2(KAPPA) AND AN IGG1/IGG3-(KAPPA) GM(F,B) HYBRID, IN A SINGLE MYELOMA PATIENT
    MILOSEVICJOVCIC, N
    DOVEZENSKI, N
    JOVANOVIC, L
    ROLOVIC, Z
    GOTIC, M
    RADOSEVIC, N
    SUVAJDZIC, N
    TOSIC, L
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 54 (05) : 288 - 295
  • [47] The syndrome of chronic mucocutaneous candidiasis with IgG2 and IgG4 subclass deficiency (and IgA deficiency)
    Kalfa, VC
    Roberts, R
    Stiehm, ER
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S193 - S193
  • [48] AFFINITY MATURATION IS REQUIRED FOR PATHOGENIC MONOVALENT IGG4 AUTOANTIBODY DEVELOPMENT IN AUTOIMMUNE MYASTHENIA GRAVIS
    Fichtner, M.
    Vieni, C.
    Redler, R.
    Kolich, L.
    Jiang, R.
    Takata, K.
    Stathopoulos, P.
    Suarez, P.
    Nowak, R.
    Burden, S.
    Ekiert, D.
    O'Connor, K.
    MUSCLE & NERVE, 2020, 62 : S119 - S119
  • [49] IgG4 but no IgG1 antibody production after intralymphatic immunotherapy with recombinant MAT-Feld1 in human
    Freiberger, S. N.
    Zehnder, M.
    Gafvelin, G.
    Gronlund, H.
    Kuendig, T. M.
    Johansen, P.
    ALLERGY, 2016, 71 (09) : 1366 - 1370
  • [50] BIOLOGICAL-ACTIVITY OF HUMAN MOUSE IGG1, IGG2, IGG3, AND IGG4 CHIMERIC MONOCLONAL-ANTIBODIES WITH ANTITUMOR SPECIFICITY
    STEPLEWSKI, Z
    SUN, LK
    SHEARMAN, CW
    GHRAYEB, J
    DADDONA, P
    KOPROWSKI, H
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) : 4852 - 4856